Loyal portfolio

Ignota Labs
Health · United Kingdom
Sam Windsor · Layla Hosseini-Gerami
About Ignota Labs
Ignota Labs is an AI drug turnaround company. They use cutting-edge explainable AI to understand toxic liabilities of drugs which have failed during development. They use these novel insights to acquire those drugs with hidden potential, fix the liability and sell them on, bringing new hope to patients.
Visit websiteIn the news
- Nov 16
Ignota Labs attends London Life Sciences Week as Tim Sparey and Omar Alkhatib represent the company.
View on LinkedIn - Nov 13
Ignota Labs shares its co-founder’s strategies for using agentic AI to analyze and refine shelved drugs at ACT 2026.
View on LinkedIn - Nov 10
Ignota Labs appoints Kelly Gray chief operating officer after her role as senior alliances manager.
View on LinkedIn - Nov 9
Ignota Labs’ leader reflects on presenting “The Second Chance,” a TEDAI Vienna talk about using AI to recover value from failed drugs.
View on LinkedIn - Nov 4
Ignota Labs seeks shelved drug assets, especially those with safety challenges, for acquisition and partnering.
View on LinkedIn - Oct 28
Ignota Labs sends co-founder Layla Hosseini-Gerami to speak at TEDAI Vienna about using AI to revive failed drug candidates.
View on LinkedIn
More from Health
See all companiesHealth · Europe
Aisel Health
Aisel Health uses AI to provide psychiatric care and mental health treatment to patients who lack access to traditional in-person therapy.
Augusta Klingsten Peytz
More about Aisel Health
Health · United States
Augusta Care
Augusta Care provides personalized in-home support and care services to adults with learning disabilities, autism, physical disabilities, and complex health needs across the UK.
Yvan Castilloux
More about Augusta Care
Health · Europe
Biostarks
Advanced at-home blood testing for data-driven wellbeing
Romain DORANGE
More about Biostarks
Aging / Longevity · Europe
Bruus
A CPG supplements brand for wellness & hydration through effervescent tablets.
Erik Linnander
More about Bruus